Revenue
$11.9m
-14.2% ↓ vs $13.9m
Rental revenue fell 14.2% as 35 Graham Street emptied for redevelopment, and the 81.8% NPAT drop reflects a large FY21 base item rather than
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY22 vs FY21
Revenue
$11.9m
-14.2% ↓ vs $13.9m
Net profit after tax
$2.9m
-81.8% ↓ vs $15.9m
Net cash inflow from operating activities
$2.3m
-54.1% ↓ vs $5m
Final dividend per share
44.0c
n/m ↑ vs 0.5c
Operating profit
$4.5m
-36.8% ↓ vs $7.1m
Profit before tax
$3.5m
-78.0% ↓ vs $15.9m
Cash and cash equivalents
$4.4m
+41.1% ↑ vs $3.1m
Total assets
$224.7m
+25.5% ↑ vs $179m
What changed
Gross borrowings climbed from $9.4m to $55.7m (+493%) and capex on investment properties rose from $15.0m to $40.4m, both reflecting the Munroe Lane development build. Total assets expanded 25.5% to $224.7m and net debt moved from $6.3m to $51.3m.
Rental revenue fell 14.2% to $11.9m, with 35 Graham Street's contribution to segmental rental income dropping from 27.9% to 13.9% as that asset transitions toward potential redevelopment. PBT fell 78.0% to $3.5m and NPAT fell 81.8% to $2.9m, which management attributes to a large item in the FY21 base. Operating cash flow halved to $2.3m, and pre-lease free cash flow widened to -$38.1m, the lower edge of the supplied historical range.
What matters
PBT dropped 78.0% and NPAT 81.8%, but FY21 included a disclosed large item that drove a 208.6% prior-year profit step-up. The cleaner operating signal is rental revenue down 14.2%, driven by 35 Graham Street vacating ahead of any redevelopment. This matters because the recurring rental base is shrinking, not just the valuation line.
The balance sheet has materially re-geared. Gross borrowings rose almost six-fold to $55.7m, lifting net debt from $6.3m to $51.3m to fund Munroe Lane. Against equity of $159.6m the absolute leverage is still moderate, but the trajectory matters: the development pipeline is being funded with debt while rental cash flow is contracting.
The development build is consuming all available cash. Capex of $40.4m against operating cash flow of $2.3m drove pre-lease FCF of -$38.1m. Operating earnings cover none of the capital commitment in this period, so the pre-leasing status and completion timing at Munroe Lane (now targeted April 2023) effectively determine when cash generation normalises.
Expectations
Release excerpts confirm Munroe Lane completion is now targeted April 2023, with management indicating the delays do not materially affect the project. The seasonal shape is uneven: HY22 delivered NPAT of $2.5m, leaving the implied second half at just $0.4m. That profile reflects when valuation and one-off items landed in the year rather than a steady run-rate.
With 35 Graham Street's contribution materially reduced and Munroe Lane not yet income-producing, FY23 rental revenue cannot be reliably extrapolated from FY22. The release also references AFFO as management's preferred earnings measure, but the specific AFFO figure is not in the supplied excerpts, which limits direct comparison against distributable-earnings expectations.
Quality of result
The supplied interpretation hint is to frame durability, and durability here is limited: these margins reflect the absence of large valuation write-downs this year rather than improved operating cash earnings, and the recurring rental base fell 14.2%.
Operating cash flow of $2.3m, down 54.1%, is the more telling gauge: it must service rising debt and contribute to a development pipeline that has already consumed $40.4m of capex. Trade debtors at $0.549m are barely changed from $0.567m, so the rise in debtor days to 16.8 (above Annolyse's normal range of around 0.9 days) is largely a denominator effect from lower revenue rather than a receivables build. Working-capital movement of -$0.1m sits within the supplied historical range, so the cash-quality story is not working capital but development spend and leverage.
Unresolved
This briefing cannot assess development yield assumptions, cap-rate sensitivities, lease covenants, or the specific composition of the FY21 large item, since those disclosures are not in the supplied context.
Chat
Ask follow-up questions about Asset Plus's FY22 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Asset Plus FY22 Annual Results Presentation
FY22 / results presentationAsset Plus FY22 Financial Statements
FY22 / financial reportcompany filing
FY22 / results announcementAsset Plus company filing
FY21 / results announcementAsset Plus company filing
FY21 / results releaseAsset Plus FY21 Annual Report
FY21 / financial reportAsset Plus company filing
HY22 / results announcementAsset Plus FY22 Interim Financial Statements
HY22 / financial reportAsset Plus NZX Interim Results Release
HY22 / results releaseAnnual Financial Results and Conference Call - Updated Time
FY22 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 3.8pp, with a distortion flag in the result.
Revenue growth context
Revenue growth was -14.2% for this reporting period.
ROE and capital efficiency
ROE was 1.8%, -8.0pp versus the prior comparable period.
Working-capital pressure
Debtor days were 17 days for this result.
Get the next Asset Plus briefing and related NZX reporting-season updates by email.